European Biotech Acquisition Corp.
EBACNASDAQFinancial Services
$11.19
$-0.52(-4.44%)
Market Cap$183500312
P/E Ratio—
52W High$14.1
52W Low$9.282
European Biotech Acquisition Corp. (EBAC) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · EBAC · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2022-12 | 2021-12 |
|---|---|---|
| Assets | ||
| Cash & ST Investments | $0.00B | $0.00B |
| Net Receivables | $0.00B | $0.00B |
| Inventory | $0.00B | $0.00B |
| Total Current Assets | $0.00B | $0.00B |
| PP&E Net | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B |
| Total Assets | $0.13B | $0.13B |
| Liabilities | ||
| Short-Term Debt | $0.00B | $0.00B |
| Accounts Payable | $0.00B | $0.00B |
| Total Current Liabilities | $0.00B | $0.00B |
| Long-Term Debt | $0.00B | $0.00B |
| Total Liabilities | $0.01B | $0.01B |
| Stockholders Equity | ||
| Retained Earnings | ($0.01B) | ($0.01B) |
| Total Stockholders Equity | $0.12B | $0.12B |
| Total Liab & Equity(computed) | $0.13B | $0.13B |
| Debt Summary | ||
| Total Debt | $0.00B | $0.00B |
| Net Debt | ($0.00B) | ($0.00B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more European Biotech Acquisition Corp. data
About European Biotech Acquisition Corp. (EBAC) Balance Sheet
European Biotech Acquisition Corp. (EBAC) balance sheet shows total assets of $0.13B with cash of $0.00B. Total liabilities are $0.01B, total debt $0.00B, and stockholders equity $0.12B.
Frequently asked questions
EBAC · 4 questionsEuropean Biotech Acquisition Corp. has total debt of $0.00B with net debt of ($0.00B).
EBAC total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10